Latest Leverage News

Greenwing Resources reports solid progress across its lithium, graphite, and polymetallic assets, unveiling plans to separate its Critical Minerals portfolio from the Que River polymetallic project in 2026. A recent scoping study highlights promising cash flow potential at Que River, while lithium prices continue to strengthen.

Globe Metals & Mining has secured A$8.67 million through private placements, eliminated all debt, and commenced construction at its fully permitted Kanyika Niobium Project in Malawi, marking a pivotal shift from feasibility to execution.

Constellation Technologies has broadened its IoT deployments into defence and healthcare sectors while improving its cash flow position in the December quarter.

IPB Petroleum is set to expand its footprint into Alaska’s National Petroleum Reserve with a major lease acquisition, supported by a recent $1.27 million capital raise. The company also plans a rebrand to Forte Energy, signalling a new chapter.

4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.

Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.

Terra Critical Minerals has completed a key acquisition in Nevada and boosted its Canadian uranium investment, positioning itself to capitalise on soaring tungsten and uranium prices.

Dundas Minerals has secured an 80% interest in the Romano Gold Project near the Gruyere Mine and raised $1.1 million to accelerate exploration and development. New leadership and advanced AI targeting signal a strategic push into Western Australia's prolific gold belts.

Cosmo Metals has completed its first drilling program at Spring Creek in NSW after nearly 30 years, revealing high-grade gold mineralisation and identifying a new antimony-rich corridor, supported by government grants to advance exploration.

Biotron Limited has successfully closed its fully subscribed rights issue, raising $1.52 million, and completed the acquisition of Sedarex Limited, positioning itself for growth in its diversified biotech portfolio.

Alterity Therapeutics has bolstered its Phase 2 data for ATH434 in Multiple System Atrophy and is advancing regulatory plans for a pivotal Phase 3 trial, supported by a robust cash position of A$49.2 million.

KGL Resources has secured A$11 million to accelerate development at its Jervois Copper-Silver-Gold Project, buoyed by soaring commodity prices and fresh leadership appointments. The company is progressing construction readiness and optimisation efforts while engaging with funding partners.